ADMA Biologics
ADMA
ADMA
105 hedge funds and large institutions have $189M invested in ADMA Biologics in 2022 Q1 according to their latest regulatory filings, with 26 funds opening new positions, 33 increasing their positions, 23 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
38% more capital invested
Capital invested by funds: $137M → $189M (+$52.3M)
19% more funds holding
Funds holding: 88 → 105 (+17)
3.89% more ownership
Funds ownership: 49.65% → 53.54% (+3.9%)
Holders
105
Holding in Top 10
3
Calls
$817K
Puts
$382K
Top Buyers
| 1 | +$5.84M | |
| 2 | +$4.21M | |
| 3 | +$3.89M | |
| 4 |
D.E. Shaw & Co
New York
|
+$3.32M |
| 5 |
Bank of Montreal
Toronto,
Ontario, Canada
|
+$1.67M |
Top Sellers
| 1 | -$5.09M | |
| 2 | -$4.71M | |
| 3 | -$2.22M | |
| 4 |
MF
Magnetar Financial
Evanston,
Illinois
|
-$1.15M |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$697K |